Update date
31 Mar 2023
Shareable Research Card
This metric view shows ViewRay, Inc. research and development expense history from SEC company facts.
Use it to verify the latest reported value, compare nearby periods, and jump to a cross-company ranking when a curated insight exists.
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Values may differ by reporting period and company taxonomy.
Return Loop
This metric history becomes more useful after the next quarterly or annual filing because the latest reported value, period, and company comparison context can all change.
Metric freshness comes from the latest SEC company fact available for this taxonomy tag and the paired company facts page.
Latest update
Latest reported research and development expense: $8,628,000. Open the source-backed page to compare this metric with the newest filing-backed context.
Update date
31 Mar 2023
Page type
Metric history
Latest period
Q1 2023
SEC-backed company facts were refreshed from filings filed on 11 May 2023.
Benchmark Context
ViewRay, Inc. is outside the visible top 120 companies for research and development expense in the current sample.
Compared with
Compared with 120 companies reporting research and development expense in USD. This keeps the comparison on the same metric and unit family.
Why this is notable
This is about 0x the current sample midpoint. Research and Development Expense is up about 9.6% versus the comparable prior period.
Peer comparisons use the same metric and compatible units only. Latest reported periods may differ across companies, so open each company page before drawing conclusions.
Plain-English Guide
R&D expense is what the company reports spending on research and development during the period.
Why people care
It helps users understand how heavily the company is investing in future products, platforms, or technology.
How to read it
Compare R&D with revenue and operating income so you can see whether innovation spending is growing faster than the rest of the business.
Compare next
Compare it with revenue, operating income, and capex to understand the mix between current spending and long-term investment.
R&D intensity varies widely by industry, so peer comparisons are most useful when businesses are genuinely comparable.
Open a live SEC-backed example
Save this filer page
Create a free account to keep this page in your watchlists and return after a new SEC filing changes the record here.
Financial Metric Page
Latest period: Q1 2023. Period end: 31 Mar 2023. Units: USD. Frequency: quarterly and annual.
The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.
Source: SEC Company Facts
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Reporting periods may differ by company.
Compare latest available Research and Development Expense levels across SEC-reporting companies, then open each company metric page for SEC-backed verification. Reporting periods may differ by company.
Which companies spend the most on R&D?
| Rank | Company | Latest value | Reported period | Next step |
|---|---|---|---|---|
| 1 | Alphabet Inc. (googl) | $61,087,000,000 | Year - 31 Dec 2025 | Open Alphabet Inc. Research and Development Expense |
| 2 | Meta Platforms, Inc. (meta) | $57,372,000,000 | Year - 31 Dec 2025 | Open Meta Platforms, Inc. Research and Development Expense |
| 3 | Merck & Co., Inc. (mrk) | $15,789,000,000 | Year - 31 Dec 2025 | Open Merck & Co., Inc. Research and Development Expense |
| 4 | Apple Inc. (aapl) | $10,887,000,000 | Quarter - 27 Dec 2025 | Open Apple Inc. Research and Development Expense |
| 5 | FORD MOTOR CO (f) | $9,400,000,000 | Year - 31 Dec 2025 | Open FORD MOTOR CO Research and Development Expense |
| 6 | TOYOTA MOTOR CORP/ (tm) | $8,585,000,000 | Year - 31 Mar 2013 | Open TOYOTA MOTOR CORP/ Research and Development Expense |
Compare periods with the same frequency first, then use YoY and TTM series to confirm whether changes are structural or one-off.
| Period | TTM Value | Value | YoY Chg | Change % | Start Date | End Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|---|---|
| Q1 2023 | $33,189,000 | $8,628,000 | +$758,000 | +9.6% | 01 Jan 2023 | 31 Mar 2023 | 10-Q | 11 May 2023 | 2023 | Q1 |
| Q4 2022 | $32,431,000 | $8,049,000 | -$1,017,000 | -11% | 01 Oct 2022 | 31 Dec 2022 | 10-K | 28 Feb 2023 | 2022 | FY |
| Q3 2022 | $33,448,000 | $8,100,000 | -$270,000 | -3.2% | 01 Jul 2022 | 30 Sep 2022 | 10-Q | 02 Nov 2022 | 2022 | Q3 |
| Q2 2022 | $33,718,000 | $8,412,000 | +$509,000 | +6.4% | 01 Apr 2022 | 30 Jun 2022 | 10-Q | 03 Aug 2022 | 2022 | Q2 |
| Q1 2022 | $33,209,000 | $7,870,000 | +$1,360,000 | +21% | 01 Jan 2022 | 31 Mar 2022 | 10-Q | 11 May 2023 | 2023 | Q1 |
| Q4 2021 | $31,849,000 | $9,066,000 | +$1,851,000 | +26% | 01 Oct 2021 | 31 Dec 2021 | 10-K | 28 Feb 2023 | 2022 | FY |
| Q3 2021 | $29,998,000 | $8,370,000 | +$3,125,000 | +60% | 01 Jul 2021 | 30 Sep 2021 | 10-Q | 02 Nov 2022 | 2022 | Q3 |
| Q2 2021 | $26,873,000 | $7,903,000 | +$1,692,000 | +27% | 01 Apr 2021 | 30 Jun 2021 | 10-Q | 03 Aug 2022 | 2022 | Q2 |
| Q1 2021 | $25,181,000 | $6,510,000 | +$173,000 | +2.7% | 01 Jan 2021 | 31 Mar 2021 | 10-Q | 06 May 2022 | 2022 | Q1 |
| Q4 2020 | $25,008,000 | $7,215,000 | +$556,000 | +8.4% | 01 Oct 2020 | 31 Dec 2020 | 10-K | 28 Feb 2023 | 2022 | FY |
| Q3 2020 | $24,452,000 | $5,245,000 | -$396,000 | -7% | 01 Jul 2020 | 30 Sep 2020 | 10-Q | 05 Nov 2021 | 2021 | Q3 |
| Q2 2020 | $24,848,000 | $6,211,000 | -$252,000 | -3.9% | 01 Apr 2020 | 30 Jun 2020 | 10-Q | 06 Aug 2021 | 2021 | Q2 |
| Q1 2020 | $25,100,000 | $6,337,000 | +$1,306,000 | +26% | 01 Jan 2020 | 31 Mar 2020 | 10-Q | 07 May 2021 | 2021 | Q1 |
| Q4 2019 | $23,794,000 | $6,659,000 | +$2,645,000 | +66% | 01 Oct 2019 | 31 Dec 2019 | 10-K | 25 Feb 2022 | 2021 | FY |
| Q3 2019 | $21,149,000 | $5,641,000 | +$1,294,000 | +30% | 01 Jul 2019 | 30 Sep 2019 | 10-Q | 06 Nov 2020 | 2020 | Q3 |
| Q2 2019 | $19,855,000 | $6,463,000 | +$2,074,000 | +47% | 01 Apr 2019 | 30 Jun 2019 | 10-Q | 31 Jul 2020 | 2020 | Q2 |
| Q1 2019 | $17,781,000 | $5,031,000 | +$1,261,000 | +33% | 01 Jan 2019 | 31 Mar 2019 | 10-Q | 01 May 2020 | 2020 | Q1 |
| Q4 2018 | $16,520,000 | $4,014,000 | -$914,000 | -19% | 01 Oct 2018 | 31 Dec 2018 | 10-K | 05 Mar 2021 | 2020 | FY |
| Q3 2018 | $17,434,000 | $4,347,000 | +$731,000 | +20% | 01 Jul 2018 | 30 Sep 2018 | 10-Q | 12 Nov 2019 | 2019 | Q3 |
| Q2 2018 | $16,703,000 | $4,389,000 | +$1,138,000 | +35% | 01 Apr 2018 | 30 Jun 2018 | 10-Q | 08 Aug 2019 | 2019 | Q2 |
| Q1 2018 | $15,565,000 | $3,770,000 | +$856,000 | +29% | 01 Jan 2018 | 31 Mar 2018 | 10-Q | 03 May 2019 | 2019 | Q1 |
| Q4 2017 | $14,709,000 | $4,928,000 | +$2,503,000 | +103% | 01 Oct 2017 | 31 Dec 2017 | 10-K | 12 Mar 2020 | 2019 | FY |
| Q3 2017 | $12,206,000 | $3,616,000 | +$962,000 | +36% | 01 Jul 2017 | 30 Sep 2017 | 10-Q | 09 Nov 2018 | 2018 | Q3 |
| Q2 2017 | $11,244,000 | $3,251,000 | +$287,000 | +9.7% | 01 Apr 2017 | 30 Jun 2017 | 10-Q | 07 Aug 2018 | 2018 | Q2 |
| Q1 2017 | $10,957,000 | $2,914,000 | -$485,000 | -14% | 01 Jan 2017 | 31 Mar 2017 | 10-Q | 10 May 2018 | 2018 | Q1 |
| Q4 2016 | $11,442,000 | $2,425,000 | -$616,000 | -20% | 01 Oct 2016 | 31 Dec 2016 | 10-K | 15 Mar 2019 | 2018 | FY |
| Q3 2016 | $12,058,000 | $2,654,000 | -$248,000 | -8.5% | 01 Jul 2016 | 30 Sep 2016 | 10-Q | 13 Nov 2017 | 2017 | Q3 |
| Q2 2016 | $12,306,000 | $2,964,000 | +$706,000 | +31% | 01 Apr 2016 | 30 Jun 2016 | 10-Q | 07 Aug 2017 | 2017 | Q2 |
| Q1 2016 | $11,600,000 | $3,399,000 | +$1,151,000 | +51% | 01 Jan 2016 | 31 Mar 2016 | 10-Q | 15 May 2017 | 2017 | Q1 |
| Q4 2015 | $10,449,000 | $3,041,000 | 01 Oct 2015 | 31 Dec 2015 | 10-K | 12 Mar 2018 | 2017 | FY | ||
| Q3 2015 | $2,902,000 | +$611,000 | +27% | 01 Jul 2015 | 30 Sep 2015 | 10-Q | 14 Nov 2016 | 2016 | Q3 | |
| Q2 2015 | $2,258,000 | 01 Apr 2015 | 30 Jun 2015 | 10-Q | 15 Aug 2016 | 2016 | Q2 | |||
| Q1 2015 | $2,248,000 | 01 Jan 2015 | 31 Mar 2015 | 10-Q | 16 May 2016 | 2016 | Q1 | |||
| Q3 2014 | $2,291,000 | 01 Jul 2014 | 30 Sep 2014 | 10-Q | 16 Nov 2015 | 2015 | Q3 |
| Period | Value | YoY Chg | Change % | Start Date | End Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|---|
| 2022 | $32,431,000 | +$582,000 | +1.8% | 01 Jan 2022 | 31 Dec 2022 | 10-K | 28 Feb 2023 | 2022 | FY |
| 2021 | $31,849,000 | +$6,841,000 | +27% | 01 Jan 2021 | 31 Dec 2021 | 10-K | 28 Feb 2023 | 2022 | FY |
| 2020 | $25,008,000 | +$1,214,000 | +5.1% | 01 Jan 2020 | 31 Dec 2020 | 10-K | 28 Feb 2023 | 2022 | FY |
| 2019 | $23,794,000 | +$7,274,000 | +44% | 01 Jan 2019 | 31 Dec 2019 | 10-K | 25 Feb 2022 | 2021 | FY |
| 2018 | $16,520,000 | +$1,811,000 | +12% | 01 Jan 2018 | 31 Dec 2018 | 10-K | 05 Mar 2021 | 2020 | FY |
| 2017 | $14,709,000 | +$3,267,000 | +29% | 01 Jan 2017 | 31 Dec 2017 | 10-K | 12 Mar 2020 | 2019 | FY |
| 2016 | $11,442,000 | +$993,000 | +9.5% | 01 Jan 2016 | 31 Dec 2016 | 10-K | 15 Mar 2019 | 2018 | FY |
| 2015 | $10,449,000 | +$1,045,000 | +11% | 01 Jan 2015 | 31 Dec 2015 | 10-K | 12 Mar 2018 | 2017 | FY |
| 2014 | $9,404,000 | +$624,000 | +7.1% | 01 Jan 2014 | 31 Dec 2014 | 10-K | 17 Mar 2017 | 2016 | FY |
| 2013 | $8,780,000 | 01 Jan 2013 | 31 Dec 2013 | 10-K | 28 Mar 2016 | 2015 | FY |